Table 1. Socio-demographic variables. Variable Group FEP ... - PLOS

Recommend Documents

Supplementary Table 2: Sociodemographic Factors Correlated ... - PLOS

.13 (.15). Predictive information about non-preventable health conditions .05 (.57) .12 (.15) .04 (.61). -.03 (.74) .09 (.35). Slight or moderate susceptibility to health.

FEP - Plos

118-227 in all chains was inserted into the POPC bilayer (containing ~187 POPC molecules) for simulation. The mutant protein structures were generated using ...

Pivot Table Introduction - FEP

This brief introduction to Excel Pivot Tables addresses the English version of MS Excel 2000. Microsoft revised the Pivot Tables feature with the 2000 version but ...

Supplementary Table 1: Sociodemographic characteristics for ... - MDPI

6. Fluid milk. Processed meats and poultry. Dairy-based desserts. Pizza & calzone. Breads and rolls. 7. Dairy-based desserts Dairy-based desserts. Fluid milk.

S1 Table. Participant demographics for study 1. Variable n ... - PLOS

Bachelor's degree. 9. 16.36%. Professional degree (MD, JD, etc). 1. 1.82%. Master's degree. 1. 1.82%. Total. 55. 100.00%. Employment (Select more than one).

S3 Table. Associations of sociodemographic and lifestyle ... - PLOS

1.00 (0.84, 1.18) 1.72 (1.30, 2.29). Never married. 0.76 (0.54, 1.07) 0.91 (0.47, ... Sometime difficult. 1.16 (1.02, 1.31) 1.36 (1.04, 1.77). Impossible/difficult always.

S5 Table. Associations of time-varying sociodemographic and ... - PLOS

0.89 (0.76, 1.04) 1.43 (1.05, 1.95). Never married. 0.95 (0.67, 1.34) 1.47 (0.74, ... Sometime difficult. 1.12 (0.98, 1.28) 0.93 (0.67, 1.29). Impossible/difficult always.

Table 1 - PLOS

May 15, 2015 - request from the corresponding author (Dr Seo, Ho ... ly if they cannot pay for medical expenses for treatment. .... To the best of our knowledge, this is the first clinical study to .... Contributed reagents/materials/analysis tools:.

Table 1 - PLOS

Aug 10, 2016 - Thus, serum concentrations of lipophilic chemicals (e.g., dioxins and ... Such 37 POPs were: 2 OCs, 3 PBDEs, PBB 153, 23 non-dioxin-like ...

Table 1 - PLOS

Sep 16, 2015 - University of Korea, St. Mary's Hospital; The Catholic University of Korea, St. Vincent's. GGT and Clinical Outcomes in HD Patients. PLOS ONE ...

Table 1 - PLOS

Dec 16, 2015 - 1 Interdisciplinary Program of Genetics, Department of Veterinary Pathobiology, College of Veterinary. Medicine and Biomedical Sciences, Texas A&M ...... genetics data analysis. Evol Bioinform Online. 2005; 1:47â50. 18.

S2 Table .1 - PLOS

symptom (fever, chills, myalgia) and at least one respiratory tract symptom (rhinorrhea, sore throat cough, hoarseness). Chan. (2007). Hong Kong, 2004-. 2005.

Supplemental Table 1 - PLOS

Slc2a3. +. NM_133753. Errfi1. BE691546. C030046G05. NM_011607. Tnc. +. +. NM_133919. Aff1. BE956940. Lonrf3. NM_011627. Tpbg. +. NM_144549. Trib1.

Table 1 - PLOS

Mar 3, 2016 - groups, food prices, and food quality and we selected 75 sittings to define the size of ... using STATA version 12.0 (Stata Corporation, College Station, ..... Neighborhood food outlets, diet, and obesity among California adults,.

Table 1 - PLOS

Aug 14, 2015 - Citation: Scruggs AK, Cioffi EA, Cioffi DL, King JAC, ...... Markiewicz M, Richard E, Marks N, Ludwicka-Bradley A. Impact of endothelial ...

Table 1 - PLOS

Apr 13, 2015 - but not transient ischemic attacks (TIAs), and who were registered at ..... pairment in the elderly in Dharavi, Mumbai. ... 2008; 47(1): 36â39. 23.

Table 1 - PLOS

May 4, 2016 - S3 Appendix contains all SPSS data analysis files for ..... (21.7 Ã 13.6 cm or 24.5 Ã 15.5 degrees) Samsung Galaxy Tab tablet positioned on a ...

Table 1. - PLOS

May 4, 2015 - ... and Hospital General del Estado de Sonora âDr. Ernesto Ramos Boursâ ...... FernÃ¡ndez-LÃ³pez JC, Zakharia F, Sikora M, Contreras AV, et al.

Supplementary Table 1 - PLOS

Lab stock. IJ640 nod1::hphR leu1.32 h-. This study. JHS335 pom1::ura4+ leu1.32 ura4-D18 h+. Lab stock. JM569 cdr2::natR h-. P. Nurse. JM555 cdr1-kanR h-.

table 1 - PLOS

bAnalyses were carried out with the tools available at the ExPASy Proteomics Server (http://expasy.org.ch/): âTranslateâ, for prediction of protein sequences; ...

Supplementary table 1 - PLOS

2.2. 2.80E-02 transcription regulator, LysR family lp_2704 (purR1). 2.6. 2.71E-05 pyrimidine operon regulator. Transport and binding proteins lp_2992 (mntH2).

Supplementary Table 1 - PLOS

Supplementary Table 1 mutation pattern full model independent model. 3. Ð. (96). (6, 4, 4). ApCPA â ApCPA. (1). (1, 1, 1). ApÐ¡pÐ¡ â ÐÑÐÑÑ. (2). (1, 1, 2).

Table 1 - PLOS

Dec 14, 2015 - This has been shown in the apple maggot (Rhagoletis pomo- nella), where populations diverged ecologically after a host shift [6]. In birds ...

Supplemental Table 1 - PLOS

Interleukin-4 (v1) 0.23. C-C motif chemokine 17 (v2) 0.18 8.3. Interleukin-6 0.35. C-C motif chemokine 2 0.23. Interleukin-7 0.20 26.0. C-C motif chemokine 21 ...

Table 1. Socio-demographic variables. Variable Group FEP ... - PLOS

Download PDF

0 downloads 0 Views 67KB Size Report

Comment

Table 1. Socio-demographic variables. Variable. Group. FEP patients (n= 69). BPD patients (n= 40). Controls (n= 148). Age, mean (SD). 35.4 (12.6). 35.9 (10.3).

Table 1. Socio-demographic variables. Variable Group FEP patients (n= 69) Age, mean (SD) 35.4 (12.6) Gender, n (%)* Male 44 (63.8%) Female 25 (36.2%) Education years, mean 15.4 (3.2) (SD)* Partnership status, n (%)* Single 41 (59.5%) Married/stable partnership 19 (27.5%) Divorced/separated 7 (10.1%) Widowed 2 (2.9%) Housing, n (%)* With original family 38 (55%) With own family 20 (29%) Alone 11 (16%) Employment status, n (%)** Full-time employment 33 (47.8%) Unemployed Student Retired Other IQ, mean (SD)** *p< 0.05 **p=0.0001

29 (42%) 5 (7.3%) 2 (2.9%) 0 93.1 (15.9)

BPD patients (n= 40) 35.9 (10.3)

Controls (n= 148) 33.1 (11.3)

12 (30%) 28 (70%) 16.5 (2.7)

87 (58.8%) 61 (41.2%) 17.8 (2.4)

23 (59%) 11 (28.2%) 5 (12.8%) 0

81 (54.7%) 64 (43.2%) 3 (2.1%) 0

18 (46.2%) 13 (33.3%) 8 (20.5%)

63 (42.6%) 75 (50.7%) 10 (6.7%)

8 (20.5%)

84 (56.8%)

27 (69.3%) 1 (2.5%) 0 3 (7.7%) 91.2 (14.6)

19 (12.8%) 40 (27%) 2 (1.4%) 3 (2%) 110.6 (14.4)

1